Amarinder Bindra
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $451,697 | 209 | 74.6% |
| Travel and Lodging | $78,474 | 265 | 13.0% |
| Consulting Fee | $55,920 | 21 | 9.2% |
| Food and Beverage | $19,423 | 353 | 3.2% |
| Education | $40.22 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139,658 | 138 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $116,584 | 160 | $0 (2024) |
| PFIZER INC. | $113,096 | 148 | $0 (2023) |
| Merck Sharp & Dohme LLC | $101,147 | 103 | $0 (2024) |
| Lilly USA, LLC | $61,405 | 97 | $0 (2024) |
| CVRx, Inc. | $56,737 | 81 | $0 (2024) |
| Abbott Laboratories | $4,989 | 39 | $0 (2024) |
| Novo Nordisk Inc | $3,995 | 2 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $2,289 | 3 | $0 (2022) |
| Medtronic Vascular, Inc. | $1,541 | 11 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,342 | 78 | CVRx, Inc. ($38,755) |
| 2023 | $22,589 | 52 | CVRx, Inc. ($17,903) |
| 2022 | $119,713 | 116 | Merck Sharp & Dohme LLC ($79,590) |
| 2021 | $91,721 | 100 | Boehringer Ingelheim Pharmaceuticals, Inc. ($54,845) |
| 2020 | $55,052 | 76 | PFIZER INC. ($35,922) |
| 2019 | $153,375 | 222 | PFIZER INC. ($64,474) |
| 2018 | $38,790 | 69 | Novartis Pharmaceuticals Corporation ($28,763) |
| 2017 | $80,972 | 137 | Novartis Pharmaceuticals Corporation ($75,660) |
All Payment Transactions
850 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $745.95 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $300.37 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/19/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $217.74 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $107.03 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $97.70 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $5.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/08/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $665.98 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.62 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/24/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Heart Failure | ||||||
| 10/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $391.96 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $97.59 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/09/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $52.79 | General |
| Category: Heart Failure | ||||||
| 10/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $359.96 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $34.00 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $153.60 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $148.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Heart Failure | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 264 | 387 | $109,138 | $29,904 |
| 2022 | 10 | 346 | 528 | $119,327 | $34,794 |
| 2021 | 3 | 210 | 286 | $43,455 | $16,575 |
| 2020 | 5 | 159 | 227 | $31,263 | $12,632 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 90 | $24,091 | $8,364 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 92 | $21,916 | $6,743 | 30.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 100 | 102 | $25,935 | $5,076 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 38 | 44 | $14,755 | $4,957 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 44 | $8,192 | $2,583 | 31.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 15 | $14,250 | $2,182 | 15.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 123 | $25,495 | $9,930 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 116 | $22,790 | $9,015 | 39.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 131 | 136 | $29,900 | $7,005 | 23.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 28 | $22,729 | $4,769 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 29 | $3,108 | $1,250 | 40.2% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 14 | 40 | $5,540 | $1,248 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,316 | $1,175 | 35.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 12 | 17 | $4,051 | $302.43 | 7.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2022 | 11 | 14 | $2,170 | $68.88 | 3.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 11 | 14 | $227.24 | $30.18 | 13.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 69 | 127 | $13,335 | $6,370 | 47.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 104 | 104 | $21,320 | $5,708 | 26.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 55 | $8,800 | $4,497 | 51.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 39 | 66 | $10,560 | $5,571 | 52.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 62 | 89 | $9,345 | $3,241 | 34.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 29 | 30 | $6,150 | $1,766 | 28.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 21 | $2,415 | $1,245 | 51.6% |
| 93750 | Evaluation of lower heart chamber assist device with physician analysis | Facility | 2020 | 12 | 21 | $2,793 | $808.44 | 28.9% |
About Amarinder Bindra
Amarinder Bindra is a Student in an Organized Health Care Education/Training Program healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1528218286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amarinder Bindra has received a total of $605,555 in payments from pharmaceutical and medical device companies, with $43,342 received in 2024. These payments were reported across 850 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($451,697).
As a Medicare-enrolled provider, Bindra has provided services to 979 Medicare beneficiaries, totaling 1,428 services with total Medicare billing of $93,905. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Cardiovascular Disease
- Location Dallas, TX
- Active Since 09/30/2008
- Last Updated 07/29/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528218286
Products in Payments
- JARDIANCE (Drug) $199,474
- VYNDAQEL (Drug) $109,760
- VERQUVO (Drug) $101,147
- ENTRESTO (Drug) $96,591
- Barostim Neo System (Device) $56,737
- Ozempic (Drug) $3,954
- CardioMEMS HF System (Device) $2,018
- Optimizer Smart System (Device) $2,000
- Circulatory Support (Device) $1,343
- HeartWare HVAD (Device) $1,208
- TEGSEDI (Drug) $946.00
- HeartMate 3 Left Ventricular Assist Device (Device) $461.95
- Impella (Device) $411.22
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $382.65
- HeartMate (Device) $375.53
- remede System (Device) $314.44
- LifeVest (Device) $299.85
- Optimizer (Device) $288.65
- LEQVIO (Drug) $174.79
- PRALUENT ALIROCUMAB INJECTION (Biological) $167.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Dallas
Ambarish Pandey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $556,167
Mary Horner, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $256,186
Dr. Allison Dipasquale, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $252,903
Michael Siah
Student in an Organized Health Care Education/Training Program — Payments: $211,953
Young Kwon, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $204,422
Dr. Jaime Almandoz, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $138,928